Our study revealed that while our understanding of PD risk is predominantly derived from European genetic studies, Model 1, utilizing summary statistics from Europeans, shows to some extent applicability across diverse populations, including Ashkenazi Jewish (harboring certain levels of European ancestry and enriched with LRRK2 and GBA1 carriers) and East Asians. Here, LRRK2 is linked to Parkinson disease.